Swiss Federal Supreme Court to adopt EU SPC case law
28-06-2018
Drazen_ / iStockphoto.com
The Swiss Federal Institute of Intellectual Property has issued a notice covering a change in the practice for granting supplementary protection certificates (SPCs), following a landmark decision by Switzerland’s highest court.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Gilead Sciences, Teva, SPC, Swiss Federal Supreme Court, Medeva, patent, harmonisation, CJEU, HIV, AIDS, Swiss Federal Institute of Intellectual Property
